Description

The vitamin preparations market in China in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for vitamin preparations. The China vitamin preparations market is segmented on the basis of product. By product, it is categorized into injection preparation, oral preparation, and topical preparation . The oral preparation segment held the largest market share in 2020.

The report has profiled some of the key players of the market such as Bayer AG, Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Guangzhou Baiyunshan Pharmaceutical Holdings Company, Roche Holding AG, Shandong Shanda Wit Science and Technology Co. Ltd., Sinopharm Xingsha Pharmaceuticals (XiaMen) Co. Ltd., Wyeth LLC, Zhejiang Medicine Co. Ltd..

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the vitamin preparations market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: injection preparation, oral preparation, and topical preparation
Years Considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders

Get a comprehensive picture of the China vitamin preparations market
Pinpoint growth sectors and trends for investment
Understand what the future of the vitamin preparations market in China looks like
Identify the competitive landscape and window of opportunity

Table of Contents

1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Vitamin Preparations Market by Product
4.1 Injection Preparation
4.2 Oral Preparation
4.3 Topical Preparation
5. Company Profiles
5.1 Bayer AG
5.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
5.3 Guangzhou Baiyunshan Pharmaceutical Holdings Company
5.4 Roche Holding AG
5.5 Shandong Shanda Wit Science and Technology Co., Ltd.
5.6 Sinopharm Xingsha Pharmaceuticals (XiaMen) Co., Ltd.
5.7 Wyeth LLC
5.8 Zhejiang Medicine Co., Ltd.
6. Appendix
6.1 About StrategyHelix
6.2 Disclaimer